Skip to main content
Clinical Trials/NCT04534400
NCT04534400RecruitingNot Applicable

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic

University Hospital, Strasbourg, France2 sites in 1 country1,000 target enrollmentStarted: September 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,000
Locations
2
Primary Endpoint
Correlation between altered pulmonary volume and ordinal severity scale

Study Overview

Brief Summary

Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example.

This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :

  1. SARS-CoV-2 infections
  2. Postoperative hypoxemic acute respiratory failure

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient with insurance covering
  • patient admitted to the participating hospitals for SARS-CoV-2 infection or postoperative acute hypoxemic respiratory failure between 01/01/2019 and 05/11/2020

Exclusion Criteria

  • patient transferred to another hospital than the participating center during the 7 days following the CT scan

Outcomes

Primary Outcomes

Correlation between altered pulmonary volume and ordinal severity scale

Time Frame: 2 days after CT scan

Secondary Outcomes

  • Correlation between altered pulmonary volume and ordinal severity scale(7 days after CT scan)

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Automated Quantification of Radiologic... | Clinical Trial